Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1972 1
1979 3
1983 4
1984 1
1985 2
1986 1
1988 3
1989 4
1990 4
1991 9
1992 6
1993 4
1994 11
1995 1
1996 5
1997 2
1998 1
1999 2
2000 4
2001 3
2002 6
2003 4
2004 7
2005 7
2006 7
2007 16
2008 10
2009 17
2010 14
2011 17
2012 18
2013 12
2014 7
2015 14
2016 21
2017 16
2018 14
2019 12
2020 13
2021 12
2022 12
2023 14
2024 16
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Post-intensive care syndrome: Recent advances and future directions.
Inoue S, Nakanishi N, Amaya F, Fujinami Y, Hatakeyama J, Hifumi T, Iida Y, Kawakami D, Kawai Y, Kondo Y, Liu K, Nakamura K, Nishida T, Sumita H, Taito S, Takaki S, Tsuboi N, Unoki T, Yoshino Y, Nishida O. Inoue S, et al. Among authors: takaki s. Acute Med Surg. 2024 Feb 20;11(1):e929. doi: 10.1002/ams2.929. eCollection 2024 Jan-Dec. Acute Med Surg. 2024. PMID: 38385144 Free PMC article. Review.
Instruments to assess post-intensive care syndrome assessment: a scoping review and modified Delphi method study.
Nakanishi N, Liu K, Kawauchi A, Okamura M, Tanaka K, Katayama S, Mitani Y, Ota K, Taito S, Fudeyasu K, Masuka Y, Yoshihiro S, Utsumi S, Nishikimi M, Masuda M, Iida Y, Kawai Y, Hatakeyama J, Hifumi T, Unoki T, Kawakami D, Obata K, Katsukawa H, Sumita H, Morisawa T, Takahashi M, Tsuboi N, Kozu R, Takaki S, Haruna J, Fujinami Y, Nosaka N, Miyamoto K, Nakamura K, Kondo Y, Inoue S, Nishida O. Nakanishi N, et al. Among authors: takaki s. Crit Care. 2023 Nov 7;27(1):430. doi: 10.1186/s13054-023-04681-6. Crit Care. 2023. PMID: 37936249 Free PMC article.
Longitudinal Single-Cell Transcriptomics Reveals a Role for Serpina3n-Mediated Resolution of Inflammation in a Mouse Colitis Model.
Ho YT, Shimbo T, Wijaya E, Kitayama T, Takaki S, Ikegami K, Miyashita K, Ouchi Y, Takaki E, Yamamoto R, Kaneda Y, Tamai K. Ho YT, et al. Among authors: takaki s. Cell Mol Gastroenterol Hepatol. 2021;12(2):547-566. doi: 10.1016/j.jcmgh.2021.04.004. Epub 2021 Apr 13. Cell Mol Gastroenterol Hepatol. 2021. PMID: 33862275 Free PMC article.
Inkjet printed (bio)chemical sensing devices.
Komuro N, Takaki S, Suzuki K, Citterio D. Komuro N, et al. Among authors: takaki s. Anal Bioanal Chem. 2013 Jul;405(17):5785-805. doi: 10.1007/s00216-013-7013-z. Epub 2013 May 16. Anal Bioanal Chem. 2013. PMID: 23677254 Review.
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma.
Mori N, Tamaki N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Mori N, et al. Among authors: takaki s. Invest New Drugs. 2024 Oct;42(5):559-565. doi: 10.1007/s10637-024-01470-y. Epub 2024 Aug 30. Invest New Drugs. 2024. PMID: 39212893
Differential signaling by lymphocyte antigen receptors.
Alberola-Ila J, Takaki S, Kerner JD, Perlmutter RM. Alberola-Ila J, et al. Among authors: takaki s. Annu Rev Immunol. 1997;15:125-54. doi: 10.1146/annurev.immunol.15.1.125. Annu Rev Immunol. 1997. PMID: 9143684 Review.
The neck burn scar contracture: a concept of effective treatment.
Akita S, Hayashida K, Takaki S, Kawakami Y, Oyama T, Ohjimi H. Akita S, et al. Among authors: takaki s. Burns Trauma. 2017 Jul 13;5:22. doi: 10.1186/s41038-017-0086-8. eCollection 2017. Burns Trauma. 2017. PMID: 28717655 Free PMC article. Review.
Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Yano S, Kawaoka T, Yamasaki S, Johira Y, Kosaka M, Shirane Y, Miura R, Amioka K, Naruto K, Yamaoka K, Fujii Y, Uchikawa S, Fujino H, Ono A, Nakahara T, Murakami E, Miki D, Tsuge M, Teraoka Y, Kouno H, Takaki S, Mori N, Tsuji K, Oka S. Yano S, et al. Among authors: takaki s. Cancers (Basel). 2023 Nov 14;15(22):5406. doi: 10.3390/cancers15225406. Cancers (Basel). 2023. PMID: 38001666 Free PMC article.
Analysis of Lenvatinib's Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma.
Amioka K, Kawaoka T, Kinami T, Yamasaki S, Kosaka M, Johira Y, Yano S, Naruto K, Ando Y, Fujii Y, Uchikawa S, Ono A, Yamauchi M, Imamura M, Kosaka Y, Ohya K, Mori N, Takaki S, Tsuji K, Masaki K, Honda Y, Kouno H, Kohno H, Morio K, Moriya T, Naeshiro N, Nonaka M, Aisaka Y, Azakami T, Hiramatsu A, Aikata H, Oka S. Amioka K, et al. Among authors: takaki s. Cancers (Basel). 2022 Oct 16;14(20):5066. doi: 10.3390/cancers14205066. Cancers (Basel). 2022. PMID: 36291850 Free PMC article.
321 results